Navigation Links
Researcher at UGA College of Veterinary Medicine identifies new way of combating viral diseases

Four seemingly unrelated viral diseases may some day be defeated by a single treatment, according to a recent collaborative study involving researchers at the University of Georgia's College of Veterinary Medicine.

Their study focuses on viruses responsible for HIV, measles, Ebola and Marburg and includes investigators from Vanderbilt University Medical Center and the Centers for Disease Control and Prevention. The study is being funded by a grant from the Hudson-Alpha Institute for Biotechnology.

In the September issue of the Journal of Virology, Thomas Hodge, research professor of infectious diseases at the veterinary college, and his colleagues report that blocking a protein that helps transport viruses out of a cell keeps these four viruses from reproducing and infecting other cells.

Most antiviral therapies target the virus itself, but viruses are quick to adapt to the body's attempts to disable them, Hodge explained. They can mutate rapidly and develop resistance to almost any antiviral compound. By focusing on the host cell while most scientists concentrate on the virus, Hodge and his colleagues hope to identify new ways to combat viral diseases.

The researchers identified a cellular protein called Rab9 ?a factor required for viruses to reproduce in a cell.Disrupting Rab9 prevented the replication of four different viruses ?Marburg, Ebola, HIV-1, and measles viruses.

"We believe that interfering with the Rab9 pathway interferes with the ability of the viruses to exit the cell, thereby dramatically decreasing the ability of the virus to spread rapidly and produce infection," Hodge said.

Because these viruses depend heavily on this exit pathway, they probably would not be able to find another route out of the cell. This suggests that Rab9 and other components of this exit pathway might be attractive targets for antiviral therapies for a variety of viruses.

Blocking Rab9 may have significant side effects, b ut there are people who live without Rab9, Hodge explained. Although they have metabolic problems, they are generally able to control their condition with diet and medication.Temporarily blocking the Rab9 pathway would be unlikely to harm the body, Hodge added, because human cells tend to have backup systems that can compensate.


'"/>

Source:University of Georgia


Related biology news :

1. Researchers discover way to make cells in the eye sensitive to light
2. Researchers find how protein allows insects to detect and respond to pheromones
3. Researchers Uncover Key Step In Manufacture of Memory Protein
4. Researchers reveal the infectious impact of salmon farms on wild salmon
5. Researchers identify target for cancer drugs
6. Researchers discover molecule that causes secondary stroke
7. Researchers find missing genes of ancient organism
8. Researchers trace evolution to relatively simple genetic changes
9. Researchers add new tool to tumor-treatment arsenal
10. UF Researchers Map Bacterial Proteins That Cause Tooth Loss
11. VCU Researchers Identify Networks Of Genes Responding To Alcohol In The Brain
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/16/2017)... 16, 2017   Bridge Patient Portal , ... MD EMR Systems , an electronic medical ... GE, have established a partnership to build an ... the GE Centricity™ products, including Centricity Practice Solution ... These new integrations will allow healthcare delivery ...
(Date:4/18/2017)... 18, 2017  Socionext Inc., a global expert in SoC-based imaging ... server, the M820, which features the company,s hybrid codec technology. A ... Tera Probe, Inc., will be showcased during the upcoming Medtec Japan ... at the Las Vegas Convention Center April ... Click here for ...
(Date:4/11/2017)... 11, 2017 Crossmatch®, a globally-recognized leader ... today announced that it has been awarded a ... Activity (IARPA) to develop next-generation Presentation Attack Detection ... "Innovation has been a driving force within Crossmatch ... allow us to innovate and develop new technologies ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... ... has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and ... of osteosarcoma. SBT-100 is able to cross the cell membrane and bind intracellular ...
(Date:10/10/2017)... , ... October 10, 2017 , ... ... Center’s FirstHand program has won a US2020 STEM Mentoring Award. Representatives of the ... for Excellence in Volunteer Experience from US2020. , US2020’s mission is to change ...
(Date:10/10/2017)... SANTA CRUZ, Calif. , Oct. 10, 2017 /PRNewswire/ ... SBIR grant from the NIH to develop RealSeq®-SC (Single ... preparation kit for profiling small RNAs (including microRNAs) from ... Cell Analysis Program highlights the need to accelerate development ... "New techniques for ...
(Date:10/9/2017)... , Oct. 9, 2017  BioTech Holdings ... mechanism by which its ProCell stem cell therapy ... limb ischemia.  The Company, demonstrated that treatment with ... of limbs saved as compared to standard bone ... molecule HGF resulted in reduction of therapeutic effect.  ...
Breaking Biology Technology: